Search research articles
Contact Us
Filters
Showing results (391-400 of 484) with videos related to
Page
of 49
Sort By:
Rheumatology (Oxford, England)
|
September 22, 2018
European multicentre study validates enhanced liver fibrosis test as biomarker of fibrosis in systemic sclerosis
Giuseppina Abignano, Jelena Blagojevic, Lesley-Anne Bissell, et al.
The American Journal of Pathology
|
June 14, 2013
Assessment of Brd4 inhibition in idiopathic pulmonary fibrosis lung fibroblasts and in vivo models of lung fibrosis
Xiaoyan Tang, Ruoqi Peng, Jonathan E Phillips, et al.
Rheumatology (Oxford, England)
|
January 31, 2024
A phase 2 trial investigating the efficacy and safety of the mPGES-1 inhibitor vipoglanstat in systemic sclerosis-related Raynaud's
Göran Tornling, Charlotte Edenius, John D Pauling, et al.
Autoimmunity Reviews
|
September 15, 2019
Fast track algorithm: How to differentiate a "scleroderma pattern" from a "non-scleroderma pattern"
Vanessa Smith, Amber Vanhaecke, Ariane L Herrick, et al.
Seminars in Arthritis and Rheumatism
|
October 12, 2023
Surgical management of digital ulcers in systemic sclerosis: A systematic literature review
Yossra A Suliman, Corrado Campochiaro, Michael Hughes, et al.
Clinical Rheumatology
|
January 10, 2020
Defining genetic risk factors for scleroderma-associated interstitial lung disease : IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease
Carmel J W Stock, Angelo De Lauretis, Dina Visca, et al.
Arthritis Research & Therapy
|
September 2, 2025
Transforming growth factor beta (TGF-β) induces type 1 interferon signalling in systemic sclerosis keratinocytes through the chloride intracellular channel 4 (CLIC4)
Christopher W Wasson, Sophie L Dibb, Begoña Caballero-Ruiz, et al.
Annals of the Rheumatic Diseases
|
May 1, 2020
Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management
Marco Matucci-Cerinic, Cosimo Bruni, Yannick Allanore, et al.
Journal of Scleroderma and Related Disorders
|
June 19, 2026
Expert recommendations for the management of fecal incontinence in systemic sclerosis: A report from the World Scleroderma Foundation (WSF) Gastrointestinal "Ad hoc committee"
Zsuzsanna H McMahan, Maria Cristina De Santis, Anna Lo Cricchio, et al.
Chest
|
December 15, 2025
Systemic Sclerosis-Associated Interstitial Lung Disease: What We Know and How to Incorporate Guidelines into Clinical Practice
Anthony J Esposito, Kavitha C Selvan, Carrie Richardson, et al.
Page
of 49
Search research articles
Search
Showing results (391-400 of 484) with videos related to
Sort By:
Page
of 49
Rheumatology (Oxford, England)
|
September 22, 2018
European multicentre study validates enhanced liver fibrosis test as biomarker of fibrosis in systemic sclerosis
Giuseppina Abignano, Jelena Blagojevic, Lesley-Anne Bissell, et al.
The American Journal of Pathology
|
June 14, 2013
Assessment of Brd4 inhibition in idiopathic pulmonary fibrosis lung fibroblasts and in vivo models of lung fibrosis
Xiaoyan Tang, Ruoqi Peng, Jonathan E Phillips, et al.
Rheumatology (Oxford, England)
|
January 31, 2024
A phase 2 trial investigating the efficacy and safety of the mPGES-1 inhibitor vipoglanstat in systemic sclerosis-related Raynaud's
Göran Tornling, Charlotte Edenius, John D Pauling, et al.
Autoimmunity Reviews
|
September 15, 2019
Fast track algorithm: How to differentiate a "scleroderma pattern" from a "non-scleroderma pattern"
Vanessa Smith, Amber Vanhaecke, Ariane L Herrick, et al.
Seminars in Arthritis and Rheumatism
|
October 12, 2023
Surgical management of digital ulcers in systemic sclerosis: A systematic literature review
Yossra A Suliman, Corrado Campochiaro, Michael Hughes, et al.
Clinical Rheumatology
|
January 10, 2020
Defining genetic risk factors for scleroderma-associated interstitial lung disease : IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease
Carmel J W Stock, Angelo De Lauretis, Dina Visca, et al.
Arthritis Research & Therapy
|
September 2, 2025
Transforming growth factor beta (TGF-β) induces type 1 interferon signalling in systemic sclerosis keratinocytes through the chloride intracellular channel 4 (CLIC4)
Christopher W Wasson, Sophie L Dibb, Begoña Caballero-Ruiz, et al.
Annals of the Rheumatic Diseases
|
May 1, 2020
Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management
Marco Matucci-Cerinic, Cosimo Bruni, Yannick Allanore, et al.
Journal of Scleroderma and Related Disorders
|
June 19, 2026
Expert recommendations for the management of fecal incontinence in systemic sclerosis: A report from the World Scleroderma Foundation (WSF) Gastrointestinal "Ad hoc committee"
Zsuzsanna H McMahan, Maria Cristina De Santis, Anna Lo Cricchio, et al.
Chest
|
December 15, 2025
Systemic Sclerosis-Associated Interstitial Lung Disease: What We Know and How to Incorporate Guidelines into Clinical Practice
Anthony J Esposito, Kavitha C Selvan, Carrie Richardson, et al.
Page
of 49